This study from the University of California San Francisco-Stanford finds that COVID-19 patients taking SSRI antidepressants, particularly fluoxetine, were significantly less likely to die from the disease.
The research team analyzed electronic health records (EHRs) from 87 healthcare centers across the US. Of 83,584 adult patients diagnosed with COVID-19 between January and September 2020, 3,401 were prescribed SSRIs.
Results showed that:
Data from EHRs allow researchers to quickly look into existing drugs that could be repurposed for treating COVID-19 or other conditions, the authors say.Read More >>